Our Approach:

Barricade Therapeutics, Corp. is a privately held biotech company based in Dallas – Fort Worth, TX. Barricade was founded based on discovery and advancement of novel first-in-class small molecules, by integrating complex molecule synthesis, chemistry, and molecular pharmacology with targeted therapeutic approaches in cancer biology. The company is focused on the development of uniquely innovative targeted drugs for the treatment of patients with cancer.

Meet the Team:

Neil Thapar

Neil Thapar, PharmD

CEO & Chief Scientific Officer

web_mk_pop

Melissa Krauth, MBA

Chief Business Officer

newjw_web_pop_200_crop

John Walling, PhD

Chief Operating Officer

Scientific Advisory Board:

jefutsw2

Jef K. Brabander, PhD

web_js_resize

Jerry Shay, PhD

nijhawan2

Deepak Nijhawan, MD, PhD

Sunil2

Sunil Sharma, MD, FACP, MBA

Board of Directors:

DB_Picture

Darlene Boudreaux, CPA

AG_Picture

Al Guillem, PhD

Neil Thapar

Neil Thapar, PharmD